1Romero S, Martinez A, Hernandez L, et al. Light's criteria revisited: consistency and comparison with new proposed alternative criteria for separating pleural transudates from exudates. Respiration, 2000, 67 (1) :18 -23.
3Porcel JM ,Pena JM. Reappraisal of the standard method (Light's criteria) for identifying pleural exudates. Med Clin(Barc) ,2006,126 ( 6 ) : 211 -3.
4Watanabe H,Anayama S, Horiuchi T, et al. Pleural effusion caused by prostaglandin E1 preparation. Chest 2003,123 (3) :952 - S.
5Pace E, Siena L, Ferraro M, et al. Role of prostaglandin E2 in the invasiveness,growth and protection of cancer cells in malignant pleuritis. Eur J Cancer,2006,42(14) :2382 -9.
6Gonlugur U, Gonlugur TE. The distinction between transudates and exudates. J Biomed Dci,2005,12(6) :985 -90.
7Sharma M, Gupta KB, Goyal KM, et al. Evaluation of cholinesterase to differential pleural exudates and transudates. J Assoc Physicians Indis, 2006,5(52) :387 -90.
8Liu CL,Hsieh WY ,Wu CL,et al. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease. Respir Med,2007,101 (5) :903 - 9.
10Akarsu S, Kurt AN, Dogan Y, et al. The differential diagnostic values of cytokine levels in pleural effusions. Mdiators inflamm, 2005,24 ( 1 ) : 2 --8.